ImmuLogic Pharmaceutical Corp. (Abridged)

ImmuLogic Pharmaceutical Corp. (Abridged): "ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The rationales for and problems of high-technology start-ups are explored. The challenges posed by 'windows' for public offerings are highlighted."